Furthermore, the same study reported that fewer Sox10+/NogoA+ cells were Myrf+ in chronic MS lesion centers than in shadow plaques, indicating that a lack of Myrf may contribute to remyelination failure in some MS lesions. Here, SOX10 is linked to myeloid sarcoma.